Patents by Inventor Emilia VÄISÄNEN

Emilia VÄISÄNEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CYP17 inhibitors/antiandrogens
    Patent number: 9890139
    Abstract: Compounds of formula (I) wherein R1 to R8, A, B, Z1, and Z2 are as defined in the claims and pharmaceutically acceptable salts and esters thereof are disclosed. The compounds of formula (I) possess utility as androgen receptor antagonists (inhibitors) and/or cytochrome P450 monooxygenase 17?-hydroxylase/17,20-lyase (CYP17) inhibitors. The compounds are useful as medicaments in the treatment of cancer, particularly prostate cancer, and other androgen dependent conditions and diseases where androgen antagonism is desired.
    Type: Grant
    Filed: June 10, 2014
    Date of Patent: February 13, 2018
    Assignee: ORION CORPORATION
    Inventors: Gerd Wohlfahrt, Petteri Rummakko, Arja Karjalainen, Mikko Passiniemi, Pekka Pietikäinen, Anssi Haikarainen, Emilia Väisänen, Eija Tiainen
  • NOVEL CYP17 INHIBITORS/ANTIANDROGENS
    Publication number: 20160130254
    Abstract: Compounds of formula (I) wherein R1 to R8, A, B, Z1, and Z2 are as defined in the claims and pharmaceutically acceptable salts and esters thereof are disclosed. The compounds of formula (I) possess utility as androgen receptor antagonists (inhibitors) and/or cytochrome P450 monooxygenase 17?-hydroxylase/17,20-lyase (CYP17) inhibitors. The compounds are useful as medicaments in the treatment of cancer, particularly prostate cancer, and other androgen dependent conditions and diseases where androgen antagonism is desired.
    Type: Application
    Filed: June 10, 2014
    Publication date: May 12, 2016
    Inventors: Gerd WOHLFAHRT, Petteri RUMMAKKO, Arja KARJALAINEN, Mikko PASSINIEMI, Pekka PIETIKÄINEN, Anssi HAIKARAINEN, Emilia VÄISÄNEN, Eija TIAINEN